Page 92 - 22-0424
P. 92

The International Journal of the Royal Society of Thailand
              Volume XI - 2019



              Maetzel D, Sarkar S, Wang H, Abi-Mosleh L, Xu P, Cheng AW, et al. Genetic and
                      chemical correction of cholesterol accumulation and impaired autophagy
                      in hepatic and neural cells derived from Niemann-Pick Type C patient-

                      specific iPS cells. Stem Cell Reports. 2014;2:866–880. doi:10.1016/j.stemcr.
                      2014.03.014.

              Nayak RC, Trump LR, Aronow BJ, Myers K, Mehta P, Kalfa T, et al. Pathogenesis
                      of ELANE-mutant severe neutropenia revealed by induced pluripotent
                      stem cells. J Clin Invest. 2015;125:3103–3116. doi:10.1172/JCI80924.
              Norbnop P, Ingrungruanglert P, Israsena N, Suphapeetiporn K, Shotelersuk V.
                      Generation and characterization of HLA-universal platelets derived from
                      induced pluripotent stem cells. Sci Rep. 2020;10:8472. doi:10.1038/s41598-
                      020-65577-x

              Panmontha W, Amarinthnukrowh P, Damrongphol P, Desudchit T, Suphapeetiporn
                      K, Shotelersuk V. Novel mutations in the FUCA1 gene that cause fucosidosis.

                      Genet Mol Res. 2016;15(3). doi:10.4238/gmr.15038733.
              Park CY, Kim DH, Son JS, Sung JJ, Lee J, Bae S, et al. Functional Correction of
                      Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-
                      Derived iPSCs Using CRISPR-Cas9. Cell Stem Cell. 2015;17(2):213–20.
                      doi:10.1016/j.stem.2015.07.001.

              Pergande M, Motameny S, Ozdemir O, Kreutzer M, Wang H, Daimaguler HS, et al.
                      The genomic and clinical landscape of fetal akinesia. Genet Med.
                      2020;22(3):511–523. doi:10.1038/s41436-019-0680-1.

              Rexach J, Lee H, Martinez-Agosto JA, Nemeth AH, Fogel BL. Clinical application
                      of next-generation sequencing to the practice of neurology. Lancet Neurol.
                      2019;18:492–503. doi:10.1016/S1474-4422(19)30033-X.

              Stein CA and Castanotto D. FDA-approved oligonucleotide therapies in 2017.
                      Mol Ther. 2017;25:1069–1075. doi:10.1016/j.ymthe.2017.03.023.

              Strafella C, Caputo V, Galota MR, Zampatti S, Marella G, Mauriello S, et al.
                      Application of precision medicine in neurodegenerative diseases. Front
                      Neurol. 2018;9:701. doi:10.3389/fneur.2018.00701.

              Striano P and Minassian BA. From genetic testing to precision medicine in epilepsy.
                      Neurotherapeutics. 2020;17: 609–615. doi:10.1007/s13311-020-00835-4.





              86                                     Precision Medicine in Hereditary Neurological Disorders:
                                                                         From Diagnosis to Treatment



                                                                                                  11/7/2565 BE   13:30
       _22-0424(077-088)8.indd   86
       _22-0424(077-088)8.indd   86                                                               11/7/2565 BE   13:30
   87   88   89   90   91   92   93   94   95   96   97